Skip to main content

Morning Exercise May Be Best for Weight Management

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Sept. 22, 2023 -- Morning appears to be the best time of day to exercise for weight management, according to a study published online Sept. 4 in Obesity.

Tongyu Ma, M.B.B.S., Ph.D., from Hong Kong Polytechnic University, and colleagues used data from 5,285 participants in the U.S. National Health and Nutrition Examination Survey (2003 to 2006) to investigate the influence of the diurnal pattern of moderate-to-vigorous physical activity (MVPA) on the association between MVPA and obesity.

The researchers found a strong linear association between MVPA and obesity in the morning group, while a weaker curvilinear association between MVPA and obesity was seen in the midday and evening groups. Among those who met the physical activity guidelines, the adjusted means for body mass index were 25.9 kg/m² in the morning group, 27.6 kg/m² in the midday group, and 27.2 kg/m² in the evening group. For waist circumference, the respective measurements for the three groups were 91.5, 95.8, and 95.0 cm, respectively.

"Morning MVPA could have a positive (i.e., obesity-protective) impact on those who are sedentary for most of the day," the authors write. "Prospective studies and randomized clinical trials are needed to confirm our findings."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.